North Star Asset Management’s ResMed RMD Stock Holding History

North Star Asset Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.79M	Buy	12,450 +710	+6%	+$177K	0.12%	126
2025 Q4	$2.83M	Buy	11,740 +1,378	+13%	+$352K	0.11%	126
2025 Q3	$2.84M	Buy	10,362 +476	+5%	+$130K	0.12%	127
2025 Q2	$2.55M	Buy	9,886 +7,845	+384%	+$1.87M	0.11%	130
2025 Q1	$457K	Sell	2,041 -97	-5%	-$22.6K	0.02%	223
2024 Q4	$489K	Sell	2,138 -80	-4%	-$19.3K	0.02%	219
2024 Q3	$541K	Sell	2,218 -237	-10%	-$53K	0.02%	216
2024 Q2	$470K	Sell	2,455 -1,879	-43%	-$381K	0.02%	215
2024 Q1	$858K	Sell	4,334 -641	-13%	-$117K	0.04%	176
2023 Q4	$856K	Sell	4,975 -1,032	-17%	-$159K	0.04%	170
2023 Q3	$888K	Sell	6,007 -625	-9%	-$113K	0.05%	166
2023 Q2	$1.45M	Sell	6,632 -610	-8%	-$136K	0.08%	148
2023 Q1	$1.59M	Sell	7,242 -270	-4%	-$58.6K	0.09%	138
2022 Q4	$1.56M	Sell	7,512 -491	-6%	-$108K	0.1%	133
2022 Q3	$1.75M	Sell	8,003 -245	-3%	-$55.8K	0.12%	124
2022 Q2	$1.73M	Sell	8,248 -8,551	-51%	-$1.82M	0.11%	128
2022 Q1	$4.07M	Sell	16,799 -1,453	-8%	-$351K	0.22%	103
2021 Q4	$4.75M	Sell	18,252 -2,355	-11%	-$611K	0.24%	97
2021 Q3	$5.43M	Sell	20,607 -2,955	-13%	-$808K	0.3%	90
2021 Q2	$5.81M	Sell	23,562 -10,927	-32%	-$2.3M	0.32%	81
2021 Q1	$6.69M	Sell	34,489 -52	-0.2%	-$10.4K	0.4%	75
2020 Q4	$7.34M	Buy	34,541 +59	+0.2%	+$11.8K	0.46%	70
2020 Q3	$5.91M	Buy	34,482 +1,192	+4%	+$220K	0.44%	71
2020 Q2	$6.39M	Buy	33,290 +1,797	+6%	+$294K	0.51%	65
2020 Q1	$4.64M	Buy	31,493 +2,198	+8%	+$350K	0.45%	76
2019 Q4	$4.54M	Sell	29,295 -728	-2%	-$105K	0.33%	86
2019 Q3	$4.06M	Buy	30,023 +373	+1%	+$48.9K	0.32%	87
2019 Q2	$3.62M	Buy	29,650 +1,779	+6%	+$197K	0.28%	94
2019 Q1	$2.9M	Buy	27,871 +10,410	+60%	+$1.07M	0.23%	100
2018 Q4	$1.99M	Sell	17,461 -430	-2%	-$46.1K	0.19%	108
2018 Q3	$2.06M	Sell	17,891 -490	-3%	-$53.7K	0.17%	115
2018 Q2	$1.9M	Sell	18,381 -550	-3%	-$55.7K	0.16%	115
2018 Q1	$1.86M	Sell	18,931 -2,052	-10%	-$194K	0.17%	113
2017 Q4	$1.78M	Sell	20,983 -4,595	-18%	-$380K	0.16%	122
2017 Q3	$1.97M	Sell	25,578 -2,330	-8%	-$178K	0.2%	112
2017 Q2	$2.17M	Sell	27,908 -1,395	-5%	-$99.8K	0.22%	108
2017 Q1	$2.11M	Sell	29,303 -15,243	-34%	-$1.05M	0.22%	106
2016 Q4	$2.76M	Sell	44,546 -890	-2%	-$54.5K	0.3%	96
2016 Q3	$2.94M	Sell	45,436 -1,010	-2%	-$67.2K	0.33%	92
2016 Q2	$2.94M	Buy	46,446 +935	+2%	+$55.1K	0.34%	90
2016 Q1	$2.63M	Buy	45,511 +2,900	+7%	+$164K	0.31%	96
2015 Q4	$2.29M	Buy	42,611 +3,480	+9%	+$196K	0.27%	103
2015 Q3	$1.99M	Buy	39,131 +5,198	+15%	+$280K	0.25%	110
2015 Q2	$1.91M	Buy	+33,933	New	+$2.14M	0.22%	115

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

North Star Asset Management's RMD Position: Q1 2026 in Review

North Star Asset Management increased its ResMed (RMD) stake by 6% in Q1 2026, buying an estimated $177K and bringing the position to 12,450 shares worth $2.79M. The position accounts for 0.12% of the portfolio, ranked #126.

North Star Asset Management first reported a position in RMD in Q2 2015 and has held it in 44 quarters since. The position peaked at $7.34M in Q4 2020. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

North Star Asset Management held 12,450 shares of ResMed worth $2.79M as of Q1 2026.
North Star Asset Management bought 710 ResMed shares in Q1 2026, an estimated $177K.
ResMed made up 0.12% of North Star Asset Management's portfolio in Q1 2026, its #126 holding.
North Star Asset Management first reported a position in ResMed in Q2 2015 and has held it in 44 quarters since.
North Star Asset Management's ResMed position peaked at $7.34M in Q4 2020.
938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on North Star Asset Management's 13F filing for Q1 2026, filed 6 May 2026.